Literature DB >> 16596471

Trisomy 21: from chromosomes to mental retardation.

Pierre L Roubertoux1, Bernard Kerdelhué.   

Abstract

The first descriptions of the trisomy 21 phenotype were by Jean-Etienne-Dominique Esquirol (1838), Edouard Séguin (1846) and later by John L. H. Down in 1862. It took more than a century to discover the extra-chromosomal origin of the syndrome commonly called "Down's syndrome" and which, we suggest, should be referred to as "Trisomy 21". In this review we are presenting the landmarks, from the pioneering description of the syndrome in 1838 to Jérôme Lejeune's discovery of the first genetic substrate for mental retardation. The sequencing of HSA21 was a new starting point that generated transcriptome studies, and we have noted that studies of gene over-expression have provided the impetus for discovering the HSA21 genes associated with trisomy 21 cognitive impairment.

Entities:  

Mesh:

Year:  2006        PMID: 16596471     DOI: 10.1007/s10519-006-9052-0

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  7 in total

1.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

2.  Dynamics of subcellular proteomes during brain development.

Authors:  Daniel B McClatchy; Lujian Liao; Ji Hyoung Lee; Sung Kyu Park; John R Yates
Journal:  J Proteome Res       Date:  2012-03-26       Impact factor: 4.466

Review 3.  Neuropsychiatric and behavioral aspects of trisomy 21.

Authors:  Jeannie Visootsak; Stephanie Sherman
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

4.  Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.

Authors:  G Pollonini; V Gao; A Rabe; S Palminiello; G Albertini; C M Alberini
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

Review 5.  When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.

Authors:  D W Meechan; T M Maynard; D Gopalakrishna; Y Wu; A S LaMantia
Journal:  Gene Expr       Date:  2007

6.  Sleep-like behavior and 24-h rhythm disruption in the Tc1 mouse model of Down syndrome.

Authors:  I Heise; S P Fisher; G T Banks; S Wells; S N Peirson; R G Foster; P M Nolan
Journal:  Genes Brain Behav       Date:  2015-02-16       Impact factor: 3.449

7.  Screening of Fetal Chromosome Aneuploidies in the First and Second Trimester of 125,170 Iranian Pregnant Women.

Authors:  Elham Seyyed Kavoosi; Sarang Younessi; Dariush D Farhud
Journal:  Iran J Public Health       Date:  2015-06       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.